These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 23177670

  • 1. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP, Paoli V, Chamorey E, Maschi C, Baillif S, Herault J, Gastaud P, Hannoun-Levi JM.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):1218-24. PubMed ID: 23177670
    [Abstract] [Full Text] [Related]

  • 2. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD.
    Am J Ophthalmol; 2004 Jun 01; 137(6):1002-10. PubMed ID: 15183783
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, Meyer A, Nauraye C, Mazal A, Mammar H, Garcia P, D'Hermies F, Frau E, Plancher C, Asselain B, Schlienger P, Mazeron JJ, Desjardins L.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):780-7. PubMed ID: 16647221
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK, Daftari IK, Weinberg V, Cole T, Quivey JM, Castro JR, Phillips TL, Char DH.
    Int J Radiat Oncol Biol Phys; 2013 Oct 01; 87(2):330-6. PubMed ID: 23886415
    [Abstract] [Full Text] [Related]

  • 6. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI, Cordini D, Dobner B, Seibel I, Gundlach E, Rehak M, Hager A, Stark R, Moser L, Joussen AM.
    Am J Ophthalmol; 2014 Nov 01; 158(5):948-56. PubMed ID: 25038327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
    Seibel I, Cordini D, Rehak M, Hager A, Riechardt AI, Böker A, Heufelder J, Weber A, Gollrad J, Besserer A, Joussen AM.
    Am J Ophthalmol; 2015 Oct 01; 160(4):628-36. PubMed ID: 26133249
    [Abstract] [Full Text] [Related]

  • 9. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
    Marucci L, Ancukiewicz M, Lane AM, Collier JM, Gragoudas ES, Munzenrider JE.
    Int J Radiat Oncol Biol Phys; 2011 Mar 01; 79(3):842-6. PubMed ID: 20472356
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD.
    Am J Ophthalmol; 2004 May 01; 137(5):893-900. PubMed ID: 15126155
    [Abstract] [Full Text] [Related]

  • 12. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A, Bergin C, Schalenbourg A, Goitein G, Zografos L.
    Ophthalmology; 2014 Apr 01; 121(4):898-904. PubMed ID: 24405742
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A, Pilger D, Cordini D, Seibel I, Riechardt AI, Joussen AM, Bechrakis NE.
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep 01; 256(9):1767-1775. PubMed ID: 29907945
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T.
    Ophthalmology; 2003 Nov 01; 110(11):2223-34. PubMed ID: 14597534
    [Abstract] [Full Text] [Related]

  • 16. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lane AM, Kim IK, Gragoudas ES.
    JAMA Ophthalmol; 2015 Jul 01; 133(7):792-6. PubMed ID: 25905597
    [Abstract] [Full Text] [Related]

  • 17. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S.
    Ophthalmology; 2005 May 01; 112(5):834-40. PubMed ID: 15878063
    [Abstract] [Full Text] [Related]

  • 18. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A, Slezak P, Chorvath M, Waczulikova I, Sramka M, Kralik G.
    Neoplasma; 2010 May 01; 57(4):377-81. PubMed ID: 20429631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.